2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemia

This publication has 13 references indexed in Scilit:

• Fulminant 2-Chlorodeoxyadenosine-Related Peripheral Neuropathy in a Patient with Paraneoplastic Neurological Syndrome Associated with Lymphoma
  Leukemia & Lymphoma, 1996
• The Comparison of 2-Chlorodeoxyadenosine (2-Cd A) in Combination with Interferon α (IFN α) or Interferon γ (IFN γ) on Granulocyte-Macrophage Progenitor Cells (CFU-GM) and Clonogenic Blasts in (CFU-L) In Vitro Cultures
  Leukemia & Lymphoma, 1996
• Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues
  European Journal Of Cancer, 1995
• The influence of 2-chloro-2′-deoxyadenosine on metabolism of deoxyadenosine in human primary CNS lymphoma
  Biochemical Pharmacology, 1995
• Cobalamin Deficiency and the Pathogenesis of Nervous System Disease
  Annual Review of Nutrition, 1992
• Metabolism and action of purine nucleoside analogs
  Pharmacology & Therapeutics, 1991
• Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group
  American Journal of Hematology, 1988
• S-Adenosylhomocysteine Hydrolase as a Pharmacological Target for the Inhibition of Transmethylation
  Published by Springer Nature ,1984
• The mechanism of inactivation of S-adenosylhomocysteinase by 2′-deoxyadenosine
  Biochemical and Biophysical Research Communications, 1980
• Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T lymphoma cells
  Cell, 1977